New data indicates Apple's App Store revenue grew to $3.4 billion in the first 35 days of its fiscal second quarter, a 6.3% year-over-year increase, as user spending continues to outpace download growth, according to a Bank of America analysis.
Wedbush Securities raises its price target on Willdan Group (WLDN) to $145, citing a robust pipeline of projects driven by infrastructure spending and energy efficiency mandates. The firm's recent acquisition is seen as a strategic move to expand its municipal advisory footprint.
The Danish pharma giant reported strong 2025 results driven by its blockbuster obesity and diabetes drugs but forecast a challenging 2026 due to pricing pressures and looming patent expiries, even as it rolls out a pivotal new oral weight-loss treatment in the U.S.
While Novo Nordisk pioneered the blockbuster GLP-1 market with Ozempic, Eli Lilly's latest earnings reveal a company pulling ahead in the battle for long-term dominance, fueled by soaring demand for Mounjaro and Zepbound.
Beeline Holdings (BLNE) has secured a pivotal integration deal, embedding its BLINKQC quality control tool directly into the dominant Encompass loan origination ecosystem. The move promises to deliver automated compliance checks to thousands of U.S. lenders within the next quarter.
Eagle FR, a subsidiary of Lakeland Industries, has won a multi-year agreement to supply its innovative Ultimate Glow+ structural firefighting gloves to seven County Fire and Rescue Services across the UK, marking a significant expansion in the competitive European safety equipment market.
Investment firm Lake Street Capital Markets has lowered its price target for Aquestive Therapeutics to $6, down from $8, while maintaining a Buy rating. The adjustment follows the company's receipt of a Complete Response Letter from the FDA for its epinephrine film Anaphylm, delaying its potential market launch.
Buzz Bomb Caffeine Company, a subsidiary of Aspire Biopharma (ASBP), has secured a strategic partnership with Blue Shark Beverages to manage and distribute its innovative sublingual caffeine product across Southern California, beginning with a Coachella Valley launch.
Private payrolls expanded at a far slower pace than anticipated last month, according to ADP data, signaling potential cooling in the labor market as hiring momentum weakens across key industries.
Joe Vitiritto, former PAM Transport CEO, has been appointed President of Knight Transportation, tasked with steering the unit through a prolonged freight downturn and driving profitable growth.
Goldman Sachs' latest Conviction List highlights five dividend-paying stocks with significant projected gains, offering investors a blend of income and growth in a volatile market.
The private sector added a mere 22,000 jobs to start 2026, signaling a persistent slowdown and raising concerns about broader economic resilience as key sectors continue to shed positions.
Orion Energy Systems secures a major contract to deploy 105 fast-charging stations for the Boston Public Schools' bus fleet, marking a significant step in the district's green transition.
Biopharmaceutical firm Ardelyx has been granted a crucial U.S. patent covering the oral formulation of its drug tenapanor, solidifying protection for its commercial products Ibsrela and Xphozah until late 2042 and bolstering its competitive position in the chronic kidney disease treatment landscape.
Biopharma firm Oragenics has enlisted Duck Flats Pharma as its regulatory strategy partner, aiming to synchronize its Australian Phase 2a trial for an intranasal concussion therapy with U.S. FDA requirements for future clinical development.
Skyward Specialty Insurance Group (SKWD) has launched a new Power Generation insurance solution aimed at small to mid-sized producers and brokers, offering customized coverage for a wide array of power assets and complementing its existing renewable energy program.
DA Davidson has upgraded Q2 Holdings (QTWO) to 'Buy,' citing an attractive valuation following a multi-month share price pullback. The firm maintains an $82 price target and projects solid organic revenue growth for the digital banking platform provider.
A new 10,000-meter drilling program aims to confirm the western extension of the Rose West lithium discovery in Quebec, a critical step toward defining an initial resource that could bolster the broader Rose Project's economic potential.
As Bitcoin's price dips below MicroStrategy's average purchase cost, critics question the sustainability of its aggressive accumulation strategy. CEO Michael Saylor remains defiant, framing volatility as a feature, not a bug, of the Bitcoin thesis.
U.S. private sector job growth fell significantly short of forecasts last month, signaling a cautious start to 2026 and heightening anticipation for delayed federal employment data.
